364 related articles for article (PubMed ID: 30133717)
21. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.
Lendvai G; Jármay K; Karácsony G; Halász T; Kovalszky I; Baghy K; Wittmann T; Schaff Z; Kiss A
World J Gastroenterol; 2014 Nov; 20(41):15343-50. PubMed ID: 25386083
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-122 as a Novel Non-Invasive Marker of Liver Fibrosis in Hepatitis C Virus Patients.
Omran AA; Osman KS; Kamel HM; Abdel-Naem EA; Hasan DE
Clin Lab; 2016 Jul; 62(7):1329-1337. PubMed ID: 28164635
[TBL] [Abstract][Full Text] [Related]
23. Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.
van der Meer AJ; Farid WR; Sonneveld MJ; de Ruiter PE; Boonstra A; van Vuuren AJ; Verheij J; Hansen BE; de Knegt RJ; van der Laan LJ; Janssen HL
J Viral Hepat; 2013 Mar; 20(3):158-66. PubMed ID: 23383654
[TBL] [Abstract][Full Text] [Related]
24. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice.
Giannini EG; Zaman A; Ceppa P; Mastracci L; Risso D; Testa R
J Clin Gastroenterol; 2006 Jul; 40(6):521-7. PubMed ID: 16825935
[TBL] [Abstract][Full Text] [Related]
25. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
26. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
[TBL] [Abstract][Full Text] [Related]
27. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients.
Motawi TM; Rizk SM; Shaker OG; Mokhtar OZ
PLoS One; 2015; 10(3):e0121524. PubMed ID: 25811198
[TBL] [Abstract][Full Text] [Related]
29. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.
Cheng JL; Zhao H; Yang SG; Chen EM; Chen WQ; Li LJ
Hepatol Int; 2018 May; 12(3):277-287. PubMed ID: 29881991
[TBL] [Abstract][Full Text] [Related]
30. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients].
Gholami M; Ravanshad M; Alavian SM; Baesi K; Moallemi S
Mol Biol (Mosk); 2016; 50(2):279-83. PubMed ID: 27239848
[TBL] [Abstract][Full Text] [Related]
32. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
33. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH
J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882
[TBL] [Abstract][Full Text] [Related]
34. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
35. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Bihrer V; Waidmann O; Friedrich-Rust M; Forestier N; Susser S; Haupenthal J; Welker M; Shi Y; Peveling-Oberhag J; Polta A; von Wagner M; Radeke HH; Sarrazin C; Trojan J; Zeuzem S; Kronenberger B; Piiper A
PLoS One; 2011; 6(10):e26971. PubMed ID: 22066022
[TBL] [Abstract][Full Text] [Related]
36. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients.
Hassuna NA; Gamil AN; Mahmoud MS; Mohamed WK; Khairy R
BMC Gastroenterol; 2022 Dec; 22(1):499. PubMed ID: 36463118
[TBL] [Abstract][Full Text] [Related]
38. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
39. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.
Halász T; Horváth G; Pár G; Werling K; Kiss A; Schaff Z; Lendvai G
World J Gastroenterol; 2015 Jul; 21(25):7814-23. PubMed ID: 26167081
[TBL] [Abstract][Full Text] [Related]
40. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Tan Y; Ge G; Pan T; Wen D; Gan J
Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
